Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer

NCT01172925 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

34

Enrollment

OTHER

Sponsor class

Conditions

NSCLC
Dyspnea

Interventions

DRUG: Tiotropium
DRUG: Placebo

Sponsor

Hamilton Health Sciences Corporation